Faeth Therapeutics
FTH
23 hedge funds and large institutions have $1.16M invested in Faeth Therapeutics in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 10 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
21% more funds holding
Funds holding: 19 → 23 (+4)
0.63% more ownership
Funds ownership: 8.77% → 9.4% (+0.63%)
12% less capital invested
Capital invested by funds: $1.32M → $1.16M (-$162K)
90% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$24.6K |
| 2 |
NAS
NWF Advisory Services
Los Angeles,
California
|
+$8.29K |
| 3 |
HF
HRT Financial
New York
|
+$5.82K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$80 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$29.5K |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$27.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$26.3K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$7.15K |
FTH Hedge Fund Activity: Q4 2024 in Review
23 of the 7,608 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q4 2024, worth a combined $1.16M — down 12% from $1.32M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FTH positions and 1 closed out — a net gain of 5 holders — while 1 added to existing stakes and 10 trimmed.
The largest buyer was XTX Topco, adding an estimated $24.6K. The largest seller was Renaissance Technologies, cutting an estimated $29.5K.
- 23 institutional investors held Faeth Therapeutics (FTH) as of Q4 2024, up from 19 in Q3 2024.
- Funds reported $1.16M of Faeth Therapeutics stock for Q4 2024, down 12% quarter-over-quarter.
- 6 funds opened new Faeth Therapeutics positions in Q4 2024 and 1 closed out, a net change of +5 holders.
- The largest Faeth Therapeutics buyer in Q4 2024 was XTX Topco, an estimated $24.6K added.
- The largest Faeth Therapeutics seller in Q4 2024 was Renaissance Technologies, an estimated $29.5K sold.
Based on aggregated 13F filings for Q4 2024.